Dr. Srinivas Gaddam, MD

Dr. Gaddam practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Gaddam's NPI, 1982815262, was assigned on May 25, 2007. Dr. Gaddam graduated from Kurnool Medical College in 2000. Dr. Gaddam holds California license A137300.

Dr. Gaddam's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Gaddam's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaddam practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gaddam's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gaddam is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gaddam's licenses on file in 2 states: California and Missouri.

Dmand AI lists bile duct problems, colonoscopy, esophagus, stomach, or upper small intestine surgery, pancreas or bile duct endoscopy (ERCP), pancreatitis and upper GI endoscopy among the conditions Dr. Gaddam treats.

CMS data shows 568 Medicare services from Dr. Gaddam across 18 procedure codes in 2024, for 271 Medicare patients. Medicare paid $84,771 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 271 Medicare patients who saw Dr. Gaddam in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gaddam's median patient age at 71, with 51% women.

In 2024, Dr. Gaddam wrote 125 Medicare Part D claims for 57 patients. 93% of them were for generic drugs. CMS names the drug for 88 of them, across 3 drugs with 11 or more claims each, at $2,846 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Gaddam for performance year 2024, reported as part of a group. Dr. Gaddam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gaddam as offering telehealth. CMS counts 492 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gaddam, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 95 papers to Dr. Gaddam, published from 2010 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Barrett Esophagus, Adenocarcinoma and Esophageal Neoplasms. Dr. Gaddam has published most often in Gastrointest Endosc. Dr. Gaddam's most frequent co-authors are Prateek Sharma, MD, Mandeep Singh, MD and Dayna S. Early, MD.

Dmand AI links Dr. Gaddam to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Genetic Predisposition to Disease and Disease Susceptibility.

CMS Open Payments shows 8 general payments to Dr. Gaddam from 6 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $2,342.

Dr. Gaddam graduated from Kurnool Medical College in 2000. Dr. Gaddam is a member of ACG, ACP, AGA and ASGE.

Dr. Gaddam is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.